ProclaimRx Launches The Next Generation Marketing Mix Modeling (MMM) Product for Commercial-Stage Biopharma Companies
PR Newswire
TIBURON, Calif., Oct. 26, 2026
Pharma-trained AI turns your MMM into a living operating model, giving commercial teams transparent, on-demand answers on how to maximize their investments.
TIBURON, Calif., Oct. 26, 2026 /PRNewswire/ -- ProclaimRx, the award-winning pharma commercial intelligence and decision workflows platform, today launched its advanced MMM product.
The MMM process has traditionally been a laborious, annual exercise. While valuable, these modeling efforts can take months to build. Often by the time the analysis and decision-making is done, brand and market dynamics have already shifted, diminishing the value of the work.
With PLAiTO™, ProclaimRx's proprietary, pharma-trained AI engine, teams can now run on-demand models using their most current data to simulate budget scenarios with data-defensible accuracy to pinpoint what's working, detect emerging signals, and provide real-time prescriptive recommendations to optimize ROI. The platform's AI engine is trained specifically for pharma, immediately understanding your data and market context. Analyses that once took weeks are completed in hours, and follow-up questions are answered immediately.
ProclaimRx's MMM provides clear insight into its findings, offering full transparency by design with no "black boxes." Every recommendation can be traced directly back to the underlying data, analysis, and core business assumptions.
"For over a decade, my teams have needed an MMM solution just like this," said Sandy Balkin, a leader of predictive analytics teams at Pfizer, Sanofi, and Boehringer Ingelheim and an advisor to ProclaimRx. "Its co-sourced model is built around each client's business rules, making methodologies, assumptions, and analyses transparent, so teams trust the results."
"Marketing leaders make multimillion-dollar decisions and can't afford to wait months for the analysis while the market is constantly changing," said Eugene Lee, CEO of ProclaimRx. "We've developed our MMM product so leaders can maximize investments with complete confidence."
ProclaimRx MMM is now available. To request a demo, visit proclaimrx.com.
About ProclaimRx
ProclaimRx is an award-winning pharma decision workflows platform purpose-built for life sciences. Founded by pharma and AI veterans, ProclaimRx empowers commercial, marketing, sales, and medical affairs teams to maximize impact and execute strategy with certainty. From launch to maturity, ProclaimRx unifies fragmented commercial data and puts the full power of your data at your fingertips, providing fast, trusted answers to your most complex business questions. And with predictive modeling, marketing mix modeling scenarios, and prescriptive recommendations, you can move beyond understanding what happened to controlling what happens next.
Media Contact
Emily Orr
Emily.Orr@proclaimrx.com
proclaimrx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/proclaimrx-launches-the-next-generation-marketing-mix-modeling-mmm-product-for-commercial-stage-biopharma-companies-302919546.html
SOURCE ProclaimRx
